| Primary |
| Drug Use For Unknown Indication |
32.0% |
| Product Used For Unknown Indication |
22.1% |
| Epilepsy |
20.1% |
| Convulsion |
5.0% |
| Drug Exposure During Pregnancy |
4.1% |
| Bipolar Disorder |
2.8% |
| Depression |
2.4% |
| Suicide Attempt |
1.9% |
| Hypertension |
1.7% |
| Affective Disorder |
0.9% |
| Insomnia |
0.8% |
| Intentional Overdose |
0.8% |
| Psychotic Disorder |
0.8% |
| Grand Mal Convulsion |
0.7% |
| Status Epilepticus |
0.7% |
| Convulsion Prophylaxis |
0.7% |
| Hiv Infection |
0.6% |
| Anxiety |
0.6% |
| Prophylaxis |
0.6% |
| Abnormal Behaviour |
0.6% |
|
| Somnolence |
10.3% |
| Epilepsy |
9.7% |
| Thrombocytopenia |
8.6% |
| Vomiting |
8.0% |
| Convulsion |
6.7% |
| Weight Increased |
6.7% |
| Tremor |
6.5% |
| Weight Decreased |
5.7% |
| Suicide Attempt |
4.0% |
| Drug Level Decreased |
3.8% |
| Pyrexia |
3.6% |
| Syncope |
3.4% |
| Drug Exposure During Pregnancy |
3.0% |
| Drug Ineffective |
3.0% |
| Drug Interaction |
3.0% |
| Petit Mal Epilepsy |
2.9% |
| Sopor |
2.9% |
| Unevaluable Event |
2.9% |
| Hyponatraemia |
2.7% |
| Medication Residue |
2.7% |
|
| Secondary |
| Epilepsy |
26.5% |
| Drug Use For Unknown Indication |
24.7% |
| Product Used For Unknown Indication |
14.5% |
| Depression |
4.6% |
| Convulsion |
4.2% |
| Bipolar Disorder |
3.7% |
| Schizophrenia |
3.6% |
| Insomnia |
3.2% |
| Hypertension |
1.8% |
| Prophylaxis |
1.8% |
| Partial Seizures |
1.5% |
| Constipation |
1.5% |
| Affective Disorder |
1.3% |
| Ill-defined Disorder |
1.2% |
| Psychotic Disorder |
1.2% |
| Drug Exposure During Pregnancy |
1.1% |
| Hiv Infection |
1.0% |
| Bipolar I Disorder |
0.9% |
| Suicide Attempt |
0.9% |
| Anxiety |
0.8% |
|
| Weight Increased |
10.6% |
| Thrombocytopenia |
10.5% |
| Somnolence |
9.4% |
| Vomiting |
7.4% |
| Epilepsy |
6.1% |
| Tremor |
5.7% |
| Weight Decreased |
5.2% |
| Pancytopenia |
4.5% |
| Self Injurious Behaviour |
4.2% |
| Status Epilepticus |
4.2% |
| Suicide Attempt |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Drug Level Decreased |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Pneumonia |
3.2% |
| Urine Abnormality |
3.2% |
| Hyponatraemia |
2.9% |
| Parkinsonism |
2.7% |
| Convulsion |
2.5% |
| Platelet Count Decreased |
2.5% |
|
| Concomitant |
| Epilepsy |
25.0% |
| Drug Use For Unknown Indication |
11.4% |
| Product Used For Unknown Indication |
10.0% |
| Depression |
6.8% |
| Prophylaxis |
6.7% |
| Hypertension |
5.2% |
| Schizophrenia |
4.8% |
| Convulsion |
4.6% |
| Bipolar Disorder |
4.4% |
| Insomnia |
3.7% |
| Hiv Infection |
3.3% |
| Constipation |
2.5% |
| Multiple Sclerosis |
1.7% |
| Bipolar I Disorder |
1.6% |
| Sedation |
1.6% |
| Pain |
1.4% |
| Infection |
1.3% |
| Diabetes Mellitus |
1.3% |
| Glioblastoma Multiforme |
1.3% |
| Pyrexia |
1.3% |
|
| White Blood Cell Count Increased |
7.8% |
| White Blood Cell Count Decreased |
7.5% |
| Pyrexia |
7.4% |
| Vomiting |
7.2% |
| Epilepsy |
6.2% |
| Somnolence |
6.0% |
| Thrombocytopenia |
5.9% |
| Pneumonia |
5.8% |
| Convulsion |
5.5% |
| Platelet Count Decreased |
4.3% |
| Rash |
4.1% |
| Weight Increased |
4.1% |
| Tremor |
3.8% |
| Status Epilepticus |
3.7% |
| Weight Decreased |
3.7% |
| Stevens-johnson Syndrome |
3.6% |
| Neutropenia |
3.5% |
| Sepsis |
3.5% |
| Renal Failure Acute |
3.3% |
| Toxic Skin Eruption |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
19.9% |
| Drug Use For Unknown Indication |
17.4% |
| Epilepsy |
8.8% |
| Schizophrenia |
8.5% |
| Schizoaffective Disorder |
7.0% |
| Hiv Infection |
5.2% |
| Convulsion |
3.3% |
| Hypertension |
3.3% |
| Bipolar Disorder |
2.9% |
| Encephalitis Cytomegalovirus |
2.6% |
| Abdominal Pain Upper |
2.5% |
| Application Site Anaesthesia |
2.1% |
| Diarrhoea |
2.1% |
| Dizziness |
2.1% |
| Feeling Abnormal |
2.1% |
| Mucosal Dryness |
2.1% |
| Polydipsia |
2.1% |
| Suffocation Feeling |
2.1% |
| Tachycardia |
2.1% |
| Visual Impairment |
2.1% |
|
| Pancreatitis Acute |
18.6% |
| Drug Interaction |
17.9% |
| Drug Level Decreased |
8.3% |
| Choking Sensation |
5.5% |
| Eructation |
5.5% |
| Pancytopenia |
5.5% |
| Status Epilepticus |
4.8% |
| Petechiae |
4.1% |
| Visual Impairment |
4.1% |
| Drug Administration Error |
3.4% |
| Medication Residue |
3.4% |
| Epilepsy |
2.8% |
| Somnolence |
2.8% |
| Fall |
2.1% |
| Insomnia |
2.1% |
| Nervous System Disorder |
2.1% |
| Rhabdomyolysis |
2.1% |
| Weight Decreased |
2.1% |
| Bradypnoea |
1.4% |
| Drug Level Increased |
1.4% |
|
